Granulomatosis with polyangiitis: Difference between revisions

No edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 4: Line 4:
*Small- and medium-sized blood vessels
*Small- and medium-sized blood vessels
*Predilection for upper and lower respiratory tracts and kidneys
*Predilection for upper and lower respiratory tracts and kidneys
{{Primary Vasculitis DDX}}


==Clinical Features==
==Clinical Features==
Line 9: Line 11:
*White, older patients
*White, older patients
*Constitutional symptoms: [[Fever]], malaise, weight loss
*Constitutional symptoms: [[Fever]], malaise, weight loss
*Upper airway: Serous [[otitis media]], hearing loss, [[sinusitis]], nasal mucosal ulcerations, septal perforation, [[epistaxis]], laryngotracheal disease
*Upper airway: Serous [[otitis media]], [[hearing loss]], [[sinusitis]], nasal mucosal ulcerations, septal perforation, [[epistaxis]], laryngotracheal disease
**Subglottic stenosis is most common laryngotracheal lesion (16% patients)
**[[Subglottic stenosis]] is most common laryngotracheal lesion (16% patients)
*Lower respiratory: [[Cough]], [[dyspnea]], pleuritis, [[hemoptysis]], [[diffuse alveolar hemorrhage]]
*Lower respiratory: [[Cough]], [[dyspnea]], pleuritis, [[hemoptysis]], [[diffuse alveolar hemorrhage]]
*[[Renal failure]], [[glomerulonephritis]]
*[[Renal failure]], [[glomerulonephritis]]
*Ophthalmologic: [[scleritis]], [[episcleritis]], [[uveitis]]
*Ophthalmologic: [[scleritis]], [[episcleritis]], [[uveitis]]
*Cutaneous: Palpable [[purpura]], nodules, ulcers
*Cutaneous: Palpable [[purpura]], nodules, ulcers
*Neurologic: Mononeuropathy and polyneuropathy, cerebral vasculitis, cerebral hemorrhage or thrombosis
*Neurologic: Mononeuropathy and polyneuropathy, cerebral vasculitis, [[ICH|cerebral hemorrhage]] or [[cerebral venous thrombosis|thrombosis]]
*Cardiac: [[Pericarditis]], [[myocarditis]]
*Cardiac: [[Pericarditis]], [[myocarditis]]


Line 25: Line 27:


==Evaluation==
==Evaluation==
===Classification===
[[File:Wegener's Granulomatosis - X-ray Case 190 (5958079204).jpg|thumb|Bilateral upper lobe nodular lesions in a patient with Granulomatosis with polyangiitis presenting with hemoptysis.]]
*American College of Rheumatology: 88% sensitivity and 92% specificity for ≥2 criteria
*Nasal or oral inflammation
*Abnormal chest radiograph showing nodules, fixed infiltrate, or cavities
*Abnormal urinary sedimentation (microscopic hematuria)
*Granulomatous inflammation on biopsy of an artery or perivascular area
===Workup===
===Workup===
*Definitive diagnosis: Biopsy
*Definitive diagnosis: Biopsy
*ANCA +, RF+
*ANCA +, RF+
*CBC: Leukocytosis, normochromic anemia, thrombocytosis
*CBC: [[Leukocytosis]], normochromic [[anemia]], [[thrombocytosis]]
*ESR/CRP elevated
*ESR/CRP elevated
*BUN/Cr
*BUN/Cr
*[[Urinalysis]] (hematuria, proteinuria)
*[[Urinalysis]] ([[hematuria]], [[proteinuria]])
*[[CXR]]- Pulmonary infiltrates and nodules
*[[CXR]]- Pulmonary infiltrates and nodules
*CT chest
*CT chest
*To consider ANA, C3 or C4, cryoglobulins, hepatitis serology, HIV, LFT, blood culture to rule out other pathology
*Consider ANA, C3 or C4, cryoglobulins, [[viral hepatitis|hepatitis serology]], HIV, [[LFTs]], blood culture to rule out other pathology
*Other tests: Bronchoscopy, PFT, sinus CT
*Other tests: Bronchoscopy, PFT, sinus CT
===Classification===
*American College of Rheumatology: 88% sensitivity and 92% specificity for ≥2 criteria
*Nasal or oral inflammation
*Abnormal chest radiograph showing nodules, fixed infiltrate, or cavities
*Abnormal urinary sedimentation (microscopic hematuria)
*Granulomatous inflammation on biopsy of an artery or perivascular area


==Management==
==Management==
*Priority: Manage pulmonary hemorrhage and renal insufficiency
*Priority: Manage pulmonary hemorrhage and renal insufficiency
**[[Difficult airway]]: Diffuse alveolar hemorrhage and subglottic stenosis
**[[Difficult airway]]: [[Diffuse alveolar hemorrhage]] and [[subglottic stenosis]]
***Fiberoptic intubation through LMA advocated
***Fiberoptic intubation through LMA advocated
*Rheumatology consult + multidisciplinary consults
*Rheumatology consult + multidisciplinary consults
*Mild disease: [[Corticosteroids]] and [[methotrexate]]
*Mild disease: [[Corticosteroids]] and [[methotrexate]]
**No active glomerulonephritis or organ-threatening disease
**No active glomerulonephritis or organ-threatening disease
*Mod-Severe disease: Corticosteroids and [[cyclophosphamide]] or [[rituximab]]
*Mod-Severe disease: [[Corticosteroids]] and [[cyclophosphamide]] or [[rituximab]]
*Corticosteroids:  
*[[Corticosteroids]]:  
**[[Methylprednisolone]] (7-15mg/kg/d with max 1000mg)
**[[Methylprednisolone]] (7-15mg/kg/d with max 1000mg)
**[[Prednisone]] 1mg/kg/d (max 80mg)
**[[Prednisone]] 1mg/kg/d (max 80mg)

Latest revision as of 17:52, 24 April 2024

Background

  • Formerly known as Wegener's granulomatosis
  • c-ANCA associated systemic necrotizing vasculitis
  • Small- and medium-sized blood vessels
  • Predilection for upper and lower respiratory tracts and kidneys

Vasculitis Syndrome Types

Clinical Features

Differential Diagnosis

Evaluation

Bilateral upper lobe nodular lesions in a patient with Granulomatosis with polyangiitis presenting with hemoptysis.

Workup

Classification

  • American College of Rheumatology: 88% sensitivity and 92% specificity for ≥2 criteria
  • Nasal or oral inflammation
  • Abnormal chest radiograph showing nodules, fixed infiltrate, or cavities
  • Abnormal urinary sedimentation (microscopic hematuria)
  • Granulomatous inflammation on biopsy of an artery or perivascular area

Management

Disposition

See Also

References